(Q45226475)

11 December 2017

Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD. (English)

1 reference

11 December 2017

restless legs syndrome

1 reference

attention deficit hyperactivity disorder

inferred from title

1 reference

6

Christine Klein

1 reference

11 December 2017

8

Rebekka Lencer

1 reference

11 December 2017

Susanne Steinlechner

1

1 reference

11 December 2017

Norbert Brüggemann

2

1 reference

11 December 2017

Vera Sobottka

3

1 reference

11 December 2017

Alexander Benthien

4

1 reference

11 December 2017

Birte Behn

5

1 reference

11 December 2017

Gabriele Schmid

7

1 reference

11 December 2017

4 September 2010

1 reference

European Archives of Psychiatry and Clinical Neuroscience

11 December 2017

1 reference

11 December 2017

261

1 reference

11 December 2017

4

1 reference

11 December 2017

285-291

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-010-0140-z

11 December 2017

0 references

cites work

How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Diagnosing and treating attention-deficit/hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Genetic basis of attention deficit and hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Adult psychiatric status of hyperactive boys grown up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Substance use among ADHD adults: implications of late onset and subthreshold diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Is ferroportin-hepcidin signaling altered in restless legs syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

[Neurobiology of attention-deficit hyperactivity disorder].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Clinical practice. Restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0140-Z

Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature

21 January 2018

1 reference

12 December 2020

Restless legs syndrome in children.

1 reference

12 December 2020

Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism

1 reference

12 December 2020

Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder

1 reference

12 December 2020

Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD

1 reference

12 December 2020

[Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist]

1 reference

12 December 2020

[Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]

1 reference

12 December 2020

Effects of levodopa on attention deficit disorder, residual type

1 reference

12 December 2020

Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients.

1 reference

12 December 2020

A family study of the hyperactive child syndrome

1 reference

12 December 2020

Oppositional defiant disorder.

1 reference

12 December 2020

10.1007/S00406-010-0140-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference